Drugs like erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality) work by blocking CGRP or its receptor
Thank you so much to Dr
Before we hopped on, we mentioned a little bit that we're noticing that there are some clinicians and researchers who, you know, are evidence-based and saying they're seeing more and more evidence that the changes that women's bodies go through, you know, specifically like bone loss, muscle loss, uh, that when they break down the research, [00:45:45] you can't attribute what's happening in a woman's body when it comes to weight loss and bone loss to just the hormone changes that are happening in paramenopause, metabolic changes, hormonal and metabolic, metabolic changes that are happening in paramenopause
Subscribe to save even more & get exactly what you need, delivered every month, conveniently to your doorstep
8 When GLP-1 receptors are activated, they promote insulin release and decrease glucagon secretion in response to glucose levels